Pharmafile Logo
Pharmafocus logo
Advanced Search
aquapharm_bertrand_lehuu

Bertrand Lehuu joins Aquapharm

March 24, 2011
Research and Development appointment, research and development

Scottish marine biotechnology company Aquapharm Biodiscovery has appointed Bertrand Lehuu as senior VP – pharma business. Bertrand has almost 30 …

Appointment

The Real-Time Rep Becomes a Reality – Changing the Rules of Engagement with Customers

March 24, 2011
Sales and Marketing

The Real-Time Rep Defined The Real-Time Rep, no longer a fictitious ideal, is a salesperson who is able to:

Feature
Thought Leadership

Budget provides UK science incentives

March 24, 2011
Research and Development George Osborne, R&D tax credits, clinical trials

Chancellor George Osborne has unveiled tax incentives, new funding and moves to cut red tape for the life sciences sector …

News
Pharma on Facebook

Digital Pharma: European pharma and social media

March 24, 2011
Medical Communications, Sales and Marketing Digital Pharma blog, Facebook, Twitter, social media, youtube

European pharma is increasingly running local social media initiatives as companies expand on their first, centrally-driven, uses of the technology.Details …

Feature

FDA delays decision on Novartis’ COPD drug

March 23, 2011
Sales and Marketing COPD, Novartis, Onbrez Breezhaler, QAB149, bronchodilator, chronic obstructive pulmonary disease, indacterol

The FDA has delayed its licence decision on Novartis’ once-daily COPD treatment QAB149 by three months. The review process will …

News

Eisai marine sponge derived cancer drug approved in Europe

March 23, 2011
Sales and Marketing Cancer, Eisai, Halaven, Halichondria okadai, breast cancer, eribulin mesylate

Eisai’s injectible breast cancer drug Halaven has been approved by European regulators. The highly novel drug is made from a …

News

Kantar Health Names Andrew Miniuks Senior Director, Oncology Market Access

March 23, 2011

Kantar Health Names Andrew Miniuks Senior Director, Oncology Market AccessNEW YORK, March 22, 2011—Kantar Health, a leading healthcare-focused global consultancy …

News
Press release
GlaxoSmithKline office

GSK to fund schools science programme

March 23, 2011
Research and Development, Sales and Marketing GSK, GlaxoSmithKline, King's College, school science

GlaxoSmithKline has followed its pledge to refund the tuition fees of UK graduates it takes on with a less direct …

News

Publicis buys Indian health advertising agency

March 23, 2011
Medical Communications Publicis Groupe, Publicis Life Brands Watermelon, Watermelon Healthcare Communications, healthcare communications agency, publicis

Publicis Groupe is to acquire a majority stake in a leading Indian healthcare advertising agency, Mumbai-based Watermelon Healthcare Communications. Publicis …

News

BMS skin cancer vaccine hits phase III target

March 23, 2011
Research and Development BMS, Bristol-Myers Squibb, advanced inoperable skin cancer, advanced melanoma, cancer drugs, cancer vaccine, ipilimumab

Bristol Myers Squibb’s cancer vaccine ipilimumab has increased overall survival in advanced melanoma patients. The therapy was being tested as …

News

Pharma manufacturing news in brief

March 22, 2011
Manufacturing and Production American Regent, Berkshire Hathaway, Cytovance, Intercell, Solagran, West Pharmaceutical Services, morphosys, pharma contract manufacturing

Lubrizol bought for $9.7 billion by Berkshire Hathaway, plus the latest pharma manufacturing and quality news. Berkshire Hathaway, run by …

News
Novartis vaccines research

Novartis increases stake in Chinese vaccines firm

March 22, 2011
Sales and Marketing China, emerging markets, vaccines

Novartis has continued its expansion into developing markets with the acquisition of a majority stake in a Chinese vaccines company. …

News
Roche's Swiss headquarters

Roche’s skin cancer drug passes mid-stage trial

March 22, 2011
Research and Development Curis, Roche, advanced basal cell carcinoma, skin cancer, vismodegib

Roche’s skin cancer candidate vismodegib has met its primary endpoint in a phase II trial. The drug is being tested …

News

Dendreon wins green light for Provenge production

March 22, 2011
Manufacturing and Production Cancer, Dendreon, FDA, Provenge, pharma manufacturing, prostate cancer vaccine, sipuleucel-T

US oncology specialist Dendreon has been boosted by the approval of additional production capacity for its therapeutic prostate cancer vaccine …

News

Lonza wins two biomanufacturing contracts

March 22, 2011
Manufacturing and Production Athera Biotechnologies, ENB-0040, Enobia Pharma, Lonza, PC-mAb, asfotase alfa, contract manufacturing, pharma, pharmaceuticals

Lonza has been awarded two contracts for biological drug candidates in quick succession, including a new deal that will make …

News

FDA and EMA join forces on quality-by-design

March 22, 2011
Manufacturing and Production EMA, FDA, QbD, Quality by Design, pharmaceutical marketing applications

The FDA has teamed up with the EMA on a new pilot programme that will allow parallel evaluation of marketing …

News

Allergan marketing breaches discredited industry

March 22, 2011
Medical Communications Allergan, Cephalon, PMCPA

Allergan, the manufacturer of Botox, has been censured for several breaches of the ABPI Code of Practice. The PMCPA watchdog …

News

Novartis gets FDA warning letter for Puerto Rico plant

March 21, 2011
Manufacturing and Production Ciba Vision, FDA manufacturing inspections, Novartis, SoftPerm contact lenses, manufacturing compliance, pharma manufacturing

A manufacturing facility operated by Novartis subsidiary Ciba Vision in Puerto Rico has been cited for manufacturing quality violations and …

News

GSK Parkinson’s drug impresses at phase III

March 21, 2011
Research and Development ADVANCE-PD, GSK, GlaxoSmithKline, IPX066, Impax Pharmaceuticals, Parkinson's disease, Parkinson’s disease

GlaxoSmithKline’s advanced Parkinson’s disease drug IPX066 has impressed in a head to head trial against it nearest rival. The phase …

News
Sanofi-Aventis HQ

Sanofi prostate cancer drug Jevtana approved in Europe

March 21, 2011
Sales and Marketing Jevtana, Sanofi-Aventis, TROPIC clinical trial, cabazitaxel, cancer drugs, chemotherapy, prostate cancer

Sanofi-Aventis’ new chemotherapy treatment Jevtana has followed up on its US approval last year by receiving the green light in …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026